Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry-Reference-Cited by-同舟云学术

Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry

Published:2016-03-30 Issue:1 Volume:18 Page:
ISSN:1478-6362
Container-title:Arthritis Research & Therapy
language:en
Short-container-title:Arthritis Res Ther

Author:

Truchetet Marie-Elise,Poursac Nicolas,Barnetche Thomas,Shipley Emilie,Gottenberg Jacques-Eric,Bannwarth Bernard,Richez Christophe,Schaeverbeke Thierry

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13075-016-0956-7

Reference35 articles.

1. Woodman I. Rheumatoid arthritis: optimizing treatment strategies in early RA. Nat Rev Rheumatol. 2013;9:695.

2. Smolen JS, Landewe R, Breedveld FC, Buch M, Burmester G, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. 2014;73:492–509.

3. de Wit MPT, Smolen JS, Gossec L, van der Heijde DM. Treating rheumatoid arthritis to target: the patient version of the international recommendations. Ann Rheum Dis. 2011;70:891–5.

4. O’Dell JR, Mikuls TR, Taylor TH, Ahluwalia V, Brophy M, Warren SR, et al. Therapies for active rheumatoid arthritis after methotrexate failure. N Engl J Med. 2013;369:307–18.

5. van der Heijde DM, Klareskog L, Rodriguez-Valverde V, Codreanu C, Bolosiu H, Melo-Gomes J, et al. Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: Two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial. Arthritis Rheum. 2006;54:1063–74.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abatacept in monotherapy vs combined in interstitial lung disease of rheumatoid arthritis—multicentre study of 263 Caucasian patients;Rheumatology;2021-03-29

2. Up to 5-year retention of abatacept in Belgian patients with moderate-to-severe rheumatoid arthritis: a sub-analysis of the international, observational ACTION study;Rheumatology International;2020-06-17

3. Subcutaneous abatacept in rheumatoid arthritis: A real-life experience;Journal of Translational Autoimmunity;2019-12

4. Analysis of the use of a selective modulator of cosmulation of T‑lymphocytes abatacept in the treatment of rheumatoid arthritis: data from international clinical practice;Medical alphabet;2019-11-26

5. The role of registries in the treatment of rheumatoid arthritis with biologic disease-modifying anti-rheumatic drugs;Pharmacological Research;2019-10